JP2022525795A5 - - Google Patents
Info
- Publication number
- JP2022525795A5 JP2022525795A5 JP2021556591A JP2021556591A JP2022525795A5 JP 2022525795 A5 JP2022525795 A5 JP 2022525795A5 JP 2021556591 A JP2021556591 A JP 2021556591A JP 2021556591 A JP2021556591 A JP 2021556591A JP 2022525795 A5 JP2022525795 A5 JP 2022525795A5
- Authority
- JP
- Japan
- Prior art keywords
- methanol
- dimethylpyrrolidine
- compound according
- hyperglycemia
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1903827.2 | 2019-03-20 | ||
| GBGB1903827.2A GB201903827D0 (en) | 2019-03-20 | 2019-03-20 | New compounds and methods |
| PCT/GB2020/050762 WO2020188301A1 (en) | 2019-03-20 | 2020-03-20 | Heterocyclyl(phenyl)methanol compounds useful in the treatment of hyperglycaemia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022525795A JP2022525795A (ja) | 2022-05-19 |
| JP2022525795A5 true JP2022525795A5 (enExample) | 2024-08-27 |
Family
ID=66381053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021556591A Pending JP2022525795A (ja) | 2019-03-20 | 2020-03-20 | 高血糖症の治療に有用なヘテロシクロリル（フェニル）メタノール化合物 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220152004A1 (enExample) |
| EP (1) | EP3941468A1 (enExample) |
| JP (1) | JP2022525795A (enExample) |
| KR (1) | KR20210141622A (enExample) |
| CN (1) | CN113784953A (enExample) |
| AU (1) | AU2020243426A1 (enExample) |
| BR (1) | BR112021018578A2 (enExample) |
| CA (1) | CA3133768A1 (enExample) |
| GB (1) | GB201903827D0 (enExample) |
| IL (1) | IL286432A (enExample) |
| MX (1) | MX2021011286A (enExample) |
| TW (1) | TWI846843B (enExample) |
| WO (1) | WO2020188301A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201714734D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714740D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714736D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201714745D0 (en) | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
| GB201903832D0 (en) | 2019-03-20 | 2019-05-01 | Atrogi Ab | New compounds and methods |
| GB202204085D0 (en) * | 2022-03-23 | 2022-05-04 | Atrogi Ab | New compounds and methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3985887A (en) * | 1973-10-19 | 1976-10-12 | Smithkline Corporation | 3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols as β-adrenergic stimulants |
| US3910933A (en) * | 1973-10-19 | 1975-10-07 | Smithkline Corp | 3-Substituted-4-hydroxyphenyl-2-piperidylcarbinols |
| NO753594L (enExample) * | 1974-10-30 | 1976-05-03 | Scherico Ltd | |
| FR2436779A1 (fr) * | 1978-09-22 | 1980-04-18 | Pharmindustrie | Derives de pyrrolidine-2 methanol utilisables comme medicaments |
| FR2460929A1 (fr) * | 1979-07-06 | 1981-01-30 | Roussel Uclaf | Nouveaux derives de l'a-phenyl 2-pyrrolidinemethanol et leur sels, procede de preparation, application a titre de medicaments et compositions les renfermant |
| EP0128120A3 (de) * | 1983-06-02 | 1985-11-13 | Ciba-Geigy Ag | Trisubstituierte Oxazolidinone |
| PT1087662E (pt) * | 1998-06-18 | 2002-09-30 | Novartis Ag | Composicao para manter afastada a vermina |
| AR019867A1 (es) * | 1998-06-18 | 2002-03-20 | Novartis Ag | Uso de un derivado de pirrolidina para la fabricacion de un repelente contra insectos, acaros y garrapatas, dicho compuesto, una composicion que locomprende, un proceso para la preparacion de dicha composicion, y un proceso para repeler insectos de lugares y materiales |
| GB0419828D0 (en) * | 2004-09-07 | 2004-10-13 | Arakis Ltd | The treatment of inflammatroy disorders and pain |
| WO2006027579A2 (en) * | 2004-09-07 | 2006-03-16 | Sosei R & D Ltd. | The treatment of inflammatory disorders and pain |
| GB2435979A (en) * | 2006-03-07 | 2007-09-12 | Helen Theresa Haywood | Door intercom telephone device |
| FR2917735B1 (fr) * | 2007-06-21 | 2009-09-04 | Sanofi Aventis Sa | Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique |
| GB201714740D0 (en) * | 2017-09-13 | 2017-10-25 | Atrogi Ab | New compounds and uses |
-
2019
- 2019-03-20 GB GBGB1903827.2A patent/GB201903827D0/en not_active Ceased
-
2020
- 2020-03-20 BR BR112021018578A patent/BR112021018578A2/pt not_active Application Discontinuation
- 2020-03-20 TW TW109109482A patent/TWI846843B/zh active
- 2020-03-20 EP EP20728536.2A patent/EP3941468A1/en active Pending
- 2020-03-20 CA CA3133768A patent/CA3133768A1/en active Pending
- 2020-03-20 CN CN202080032751.5A patent/CN113784953A/zh active Pending
- 2020-03-20 AU AU2020243426A patent/AU2020243426A1/en not_active Abandoned
- 2020-03-20 WO PCT/GB2020/050762 patent/WO2020188301A1/en not_active Ceased
- 2020-03-20 KR KR1020217033753A patent/KR20210141622A/ko not_active Ceased
- 2020-03-20 MX MX2021011286A patent/MX2021011286A/es unknown
- 2020-03-20 US US17/439,668 patent/US20220152004A1/en active Pending
- 2020-03-20 JP JP2021556591A patent/JP2022525795A/ja active Pending
-
2021
- 2021-09-14 IL IL286432A patent/IL286432A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022525795A5 (enExample) | ||
| CN1040323C (zh) | 噻唑烷衍生物 | |
| JPWO2022138987A5 (enExample) | ||
| JP2024050527A5 (enExample) | ||
| TWI299991B (en) | Cetp inhibitors | |
| RU2470011C2 (ru) | Циклоалкиламины, содержащие в качестве заместителя фенил, как ингибиторы обратного захвата моноаминов | |
| JP2022501430A5 (enExample) | ||
| JP2024001048A5 (enExample) | ||
| JP2004518763A5 (enExample) | ||
| WO2009062371A1 (fr) | Dérivés de carbamate et utilisation en tant que médicament | |
| JP2004518723A5 (enExample) | ||
| JP2022534704A5 (enExample) | ||
| RU2008119651A (ru) | Производные дикарбоновых кислот и их применение | |
| JP2024516033A5 (enExample) | ||
| CN111601797A (zh) | 苯并哌啶或杂芳基并哌啶类衍生物、其制备方法及其在医药上的应用 | |
| JP2020534266A5 (enExample) | ||
| JP2022537521A5 (enExample) | ||
| JP2020111571A5 (enExample) | ||
| JP2024520654A5 (enExample) | ||
| JP2023553428A5 (enExample) | ||
| JP2024542881A5 (enExample) | ||
| JP2024544698A5 (enExample) | ||
| CA2526989A1 (en) | Hydroxyamidine and hydroxyguanidine compounds as urokinase inhibitors | |
| CN113831338A (zh) | 一种组蛋白去乙酰化酶抑制剂及其制备方法和应用 | |
| JP2006513222A5 (enExample) |